447 related articles for article (PubMed ID: 18058076)
21. Primary Aldosteronism: Present and Future.
Funder JW
Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
[TBL] [Abstract][Full Text] [Related]
22. [Primary hyperaldosteronism].
van den Meiracker AH; Deinum J
Ned Tijdschr Geneeskd; 2003 Aug; 147(33):1580-5. PubMed ID: 12951726
[TBL] [Abstract][Full Text] [Related]
23. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
24. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic aldosteronism masquerading as discrete aldosterone-secreting adrenal cortical neoplasms among patients with primary aldosteronism.
McLeod MK; Thompson NW; Gross MD; Grekin RJ
Surgery; 1989 Dec; 106(6):1161-7; discussion 1168. PubMed ID: 2588119
[TBL] [Abstract][Full Text] [Related]
27. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.
Omura M; Sasano H; Fujiwara T; Yamaguchi K; Nishikawa T
Metabolism; 2002 Mar; 51(3):350-5. PubMed ID: 11887172
[TBL] [Abstract][Full Text] [Related]
28. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of primary aldosteronism: an updated review.
Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
[TBL] [Abstract][Full Text] [Related]
30. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
[TBL] [Abstract][Full Text] [Related]
31. Primary aldosteronism and pregnancy.
Morton A
Pregnancy Hypertens; 2015 Oct; 5(4):259-62. PubMed ID: 26597737
[TBL] [Abstract][Full Text] [Related]
32. [Primary aldosteronism].
Vetter W; Vetter H; Nussberger J; Witassek F; Beckerhoff R; Pouliadis G; Braun KP; Sobbe A; Furrer J; Siegenthaler W
Schweiz Med Wochenschr; 1976 Apr; 106(14):469-74. PubMed ID: 1265463
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and therapy of primary aldosteronism: new aspects].
Asbach E; Reincke M
Dtsch Med Wochenschr; 2022 Jan; 147(3):92-97. PubMed ID: 35100641
[TBL] [Abstract][Full Text] [Related]
34. Primary aldosteronism: diagnostic and therapeutic considerations.
Nishizaka MK; Calhoun DA
Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
[TBL] [Abstract][Full Text] [Related]
35. Primary aldosteronism.
Fardella CE; Mosso L
Clin Lab; 2002; 48(3-4):181-90. PubMed ID: 11934220
[TBL] [Abstract][Full Text] [Related]
36. Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension.
Ardhanari S; Kannuswamy R; Chaudhary K; Lockette W; Whaley-Connell A
Adv Chronic Kidney Dis; 2015 May; 22(3):185-95. PubMed ID: 25908467
[TBL] [Abstract][Full Text] [Related]
37. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
38. Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.
Nagasawa M; Yamamoto K; Rakugi H; Takeda M; Akasaka H; Umakoshi H; Tsuiki M; Takeda Y; Kurihara I; Itoh H; Ichijo T; Katabami T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Ogo A; Okamura S; Miyauchi S; Yanase T; Suzuki T; Kawamura T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1493-1499. PubMed ID: 31033727
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review.
Steichen O; Zinzindohoué F; Plouin PF; Amar L
Horm Metab Res; 2012 Mar; 44(3):221-7. PubMed ID: 22395801
[TBL] [Abstract][Full Text] [Related]
40. Selection of patients for surgery for primary aldosteronism.
Plouin PF; Rossignol P; Amar L
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):522-5. PubMed ID: 18307754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
